The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 608.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 6.00 (0.984%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 608.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

24 Jun 2013 07:00

RNS Number : 6329H
Porvair PLC
24 June 2013
 



For immediate release 24 June 2013

 

Porvair plc

Half yearly results for the six months ended 31 May 2013

 

Porvair plc ("Porvair" or "the Group"), the specialist filtration and environmental technology group, today announces its half year results for the six months ended 31 May 2013.

 

Highlights

·; Encouraging financial performance

o Revenue grew by 8% (7% in constant currency) to £38.6m (2012: £35.9m).

o Profit before tax increased by 27% to £3.1m (2012: £2.4m).

o Earnings per share up 23% to 4.9 pence (2012: 4.0 pence).

o Net debt reduced by 22% to £3.0m (30 November 2012: £3.9m).

·; Microfiltration:

o Revenue increased 15%.

o Order position strong, with several large contracts announced in the half year.

o $5.5m acquisition of Chand Eisenmann Metallurgical completed on 4 June 2013, expected to be immediately earnings enhancing.

o Expansion in USA.

·; Metals Filtration:

o Revenue 4% lower in line with management's expectations following global aluminium production curtailments. Resumption of growth expected in second half.

o Patent protection further extended.

o Further new product development making good progress.

o Expansion in China.

·; Interim dividend of 1.1 pence (2012: 1.0 pence) declared.

 

Commenting on the outlook, Ben Stocks, Chief Executive, said:

"Porvair's strategic direction and operating objectives remain consistent and continue to produce good results. We focus on niche markets which have structural growth drivers. 2013 has started satisfactorily and order books are healthy across the Group. Whilst some of our US markets have been quieter in the year to date, this has been balanced by strength elsewhere. The Board remains cautious about the general economic outlook but the second half has started well and we currently expect to see growth across the business in the rest of 2013. There remains plenty of opportunity in the Porvair businesses. We continue to invest in: new product development; US expansion for Microfiltration; and enlarged Chinese facilities for Metals Filtration. The Board's outlook remains positive and management's expectations for the year have increased."

 

For further information please contact:

Porvair plc

0207 466 5000

today

Ben Stocks, Chief Executive

01553 765 500

thereafter

Chris Tyler, Group Finance Director

Buchanan

0207 466 5000

Charles Ryland / Helen Greenwood / Clare Akhurst

www.buchanan.uk.com

 

An analyst briefing will take place at 9.30 a.m. on Monday 24 June at Buchanan. An audio webcast and a copy of the presentation will be available at www.porvair.com on the day.

Chief Executive's review

Overview

Porvair has continued to make progress against its objectives for the year as is shown in the results for the six months ended 31 May 2013. Revenue grew 8% to £38.6m (2012: £35.9m); profit before tax grew 27% to £3.1m (2012: £2.4m); and earnings per share increased by 23% to 4.9 pence (2012: 4.0 pence).

 

The second half of 2013 has started with order books at record levels, helped by large contracts announced earlier in the year. Demand across the Group is generally good, with weakness in some US markets more than offset by strength elsewhere. The fundamentals of the markets in which the Group operates - aviation, energy and industrial process, environmental laboratory supplies, and molten metals - look satisfactory.

 

Progress made against the Group's key objectives in the period to date include:

 

Microfiltration:

·; Signing further large contracts in energy filtration. This work will underpin our manufacturing and financial performance over the next few years.

·; Expansion of facilities and capabilities in US operations.

·; Acquisition of Chand Eisenmann Metallurgical. Considerable cross-selling and product development opportunities are expected.

·; Expansion of Seal Analytical capabilities following 2012 acquisitions.

Metals filtration:

·; Continuing market share gains from patented products.

·; Range extensions to broaden market acceptance.

·; Work well underway on the next generation of new products.

·; Investment in expansion of facilities in China.

 

Porvair's activities and strategy

Porvair specialises in filtration and related environmental technology. We operate two divisions. The Microfiltration division principally serves aviation, environmental laboratory and energy markets. The Metals Filtration division serves global aluminium, NAFTA iron foundry and super-alloy markets. These are niche markets which have clear structural drivers of growth. Over 80% of Group revenue is from consumable products with replacement sales at regular intervals.

 

The Group manufactures in the UK, US, Germany and China. Its sales are global.

Porvair's strategy for growth and the creation of sustainable shareholder value is to:

·; Develop filtration and environmental technology positions in markets where typically:

o specialist design or engineering skills win business;

o regulation or quality accreditation requirements mandate product use;

o consumable products, which protect more costly downstream components, are often replaced as part of a maintenance routine; and

o products, once designed into a specification, have very long lifecycles.

·; Focus on selected markets which have good long term growth prospects and are fundamentally cash generative: aviation, energy and industrial process, environmental laboratory supplies and molten metals.

·; Invest consistently in new products.

·; Expand geographically, where appropriate, in our chosen markets.

·; Acquire complementary businesses that meet Group financial and commercial criteria.

·; Generate sufficient cash to sustain a progressive dividend policy and maintain an appropriately funded balance sheet.

 

Operating review

 

Microfiltration

Revenue from Microfiltration grew by 15% to £24.5m (2012: £21.3m). Operating profits grew 43% to £3.5m (2012: £2.4m). Substantial progress was made in this division during the period:

 

Several large contracts are now underway. All are proceeding to plan but have a limited impact on these results. Under the $10m POSCO contract announced in 2011, the division is scheduled to make its second delivery later in 2013. This project is to design and build a char filtration system for a coal to substitute natural gas installation at Gwangyang, South Korea. A larger contract for a similar project was signed in February 2013 with Reliance Industries for their installation at Jamnagar, India. The scope of this work was extended in April. Finally, an £11m contract with the UK Government was announced in January 2013, for deliveries starting in 2014. All three projects will impact the financial results of the Group over several years, initially in reported working capital, but also in reported sales and margins as the projects are managed through to completion.

 

In addition to these contracts, orders in the energy and industrial sector have been robust and are well ahead of the prior year both in Europe and the US. Aerospace continues to grow steadily with growth rates slightly lower than expected due to delays in the production scale up of the Boeing 787. Sales of previously announced products for aviation inerting and coolant filters are growing as planned.

 

We have expanded our US capabilities in both industrial and aerospace manufacturing and have invested in facilities and training. This work continues and will provide a platform for growth in both market segments.

 

The acquisition of the trade and assets of Chand Eisenmann Metallurgical ("CEM") for $5.5m was completed on 4 June 2013. CEM make a broad range of powdered metal industrial filters, selling largely in the US and Canada. There is a good fit between the two businesses and we see a host of cross selling and new product development opportunities. We will be investing in the CEM plant in Maine over the next 12 months to allow room for expansion.

 

Seal Analytical revenues grew 14% in the first half, helped by 2012 acquisitions and strong underlying demand in China. Its US markets have been quieter than normal since the last quarter of 2012. Current enquiry levels are however robust, boding well for the balance of the year. Production of the range of discrete analysers acquired in December 2012 has started. Unit margins, design flexibility and product development opportunities have improved as a result.

 

Bioscience filtration remains a small but interesting part of the Group. A business unit has been set up in collaboration with the University of Swansea to develop Chromatrap™, a filtration product for epigenetic research. This remains in its R&D phase. Consideration is being given to licensing other aspects of our bioscience capabilities.

 

Metals Filtration

Revenue was 4% (5% in constant currency) lower than 2012 with operating margins maintained. This was due to some modest retrenchment in aluminium filtration caused in part by lower global aluminium prices. As noted in previous announcements, this was expected and operating budgets were set accordingly. Compared to record levels of sales in 2012 the division's performance is down, but the Board notes that the business has proved more robust than has previously been the case in such circumstances. Moreover, steady market share gains over the last two years lead us to expect a resumption of revenue growth in the second half. There remains plenty of opportunity in this division.

 

Market share gains are driven by growing customer adoption of our patented range of filters: Selee CSX for aluminium; Selee SA for NiCo alloys; and Selee IC for grey and ductile iron. Patents for IC and CSX have now been granted in China. All three are widely accepted due to their better environmental impact and filtration efficiency. Further incremental product improvements are being made to the CSX and IC products to broaden their market appeal and offer range extensions.

 

As announced at the start of the year, we are making a series of investments in this division. Having outgrown our Chinese plant we are building a larger facility at Wuhan. We expect this to be finished in the second half of the year, in time for two $1m+ orders from new Chinese aluminium smelters due for delivery in 2014.

 

Good progress is being made with the next generation of filters under development. There are two programmes that look promising, both targeted at niche metals filtration opportunities. This work takes time, but early customer trials on one of the two have started and production processes for both are being developed.

 

Last year's Pell Industries acquisition is fully integrated. The Pell process is unusual and produces products with longer lives than competitive materials. The benefits and opportunities of this are starting to show through in results.

 

Earnings per share and dividends

The basic earnings per share for the period increased 23% to 4.9 pence (2012: 4.0 pence). The Board is declaring an interim dividend of 1.1 pence (2012: 1.0 pence) per share, in line with the Group's progressive dividend policy.

 

Cash flow and net debt

Cash generated from operations in the six months to 31 May 2013 was £2.0m (2012: £3.9m). This variance is, in part, accounted for by working capital movements associated with the large contracts discussed above. As these contracts progress, working capital movements, while predictable, are likely to be more substantial than previously.

 

Net interest paid was £0.2m (2012: £0.3m). Tax payments increased to £0.8m (2012: £0.3m) due to higher profits and the end of utilisation of the US tax losses. Capital expenditure purchases were £0.5m (2012: £0.9m).

 

Closing net debt at 31 May 2013 was £3.0m (30 November 2012: 3.9m).

 

Current trading and outlook

"Porvair's strategic direction and operating objectives remain consistent and continue to produce good results. We focus on niche markets which have structural growth drivers. 2013 has started satisfactorily and order books are healthy across the Group. Whilst some of our US markets have been quieter in the year to date, this has been balanced by strength elsewhere. The Board remains cautious about the general economic outlook but the second half has started well and we currently expect to see growth across the business in the rest of 2013. There remains plenty of opportunity in the Porvair businesses. We continue to invest in: new product development; US expansion for Microfiltration; and enlarged Chinese facilities for Metals Filtration. The Board's outlook remains positive and management's expectations for the year have increased."

 

Ben Stocks

Group Chief Executive

 

 

Related parties

There were no related party transactions in the six months ended 31 May 2013 (2012: none).

 

Principal risks

Each division considers strategic, operational and financial risks and identifies actions to mitigate those risks. These risk profiles are reviewed by the Board and updated at least annually. The principal risks and uncertainties for the remaining six months of the financial year are discussed below. Further details of the Group's risk profile analysis can be found in the Annual Report for the year ended 30 November 2012.

 

Certain elements of the Group's order position, although healthy at 31 May 2013, can change quickly in the face of changing economic circumstances. The Metals Filtration division and environmental laboratory supplies and general industrial filtration within the Microfiltration division all have relatively short lead times and order cycles and, therefore, revenues are subject to fluctuations, which could have a material effect on the Group's results for the balance of 2013.

 

The Microfiltration division serves several customers whose orders are large relative to Porvair's overall order book. Should any of these be cancelled or delayed it may affect the Group's results for the balance of 2013.

 

Forward looking statements

Certain statements in this half yearly financial information are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements.

 

We undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

 

 

 

 

 

 

Consolidated income statement

For the six months ended 31 May

Six months ended 31 May

2013

2012

Note

Unaudited

Unaudited

£'000

£'000

Revenue

1

38,604

35,866

Cost of sales

(25,406)

(23,330)

Gross profit

13,198

12,536

Other operating expenses

(9,738)

(9,719)

Operating profit

1

3,460

2,817

Interest payable and similar charges

(410)

(410)

Profit before income tax

3,050

2,407

Income tax expense

(951)

(718)

Profit for the period attributable to shareholders

2,099

1,689

Earnings per share (basic)

2

4.9p

4.0p

Earnings per share (diluted)

2

4.9p

4.0p

 

 

 

 

Consolidated statement of comprehensive income

For the six months ended 31 May

Six months ended 31 May

2013

Unaudited

2012

Unaudited

£'000

£'000

Profit for the period

2,099

1,689

Other comprehensive income:

Exchange differences on translation of foreign subsidiaries

323

146

Changes in fair value of interest rate swaps held as a cash flow hedge

34

46

Net other comprehensive income

357

192

Total comprehensive income for the period attributable to shareholders of Porvair plc

 

2,456

 

1,881

 

The accompanying notes are an integral part of this interim financial information.

 

 

Consolidated balance sheet

As at 31 May

 

As at 31 May

As at 30 November

Note

2013

Unaudited

2012

Unaudited

2012

Audited

£'000

£'000

£'000

Non-current assets

Property, plant and equipment

4

8,185

8,645

8,641

Goodwill and other intangible assets

4

39,986

40,372

39,983

Deferred tax asset

2,385

1,802

1,996

50,556

50,819

50,620

Current assets

Inventories

11,211

10,677

10,258

Trade and other receivables

12,817

12,235

11,911

Derivative financial instruments

-

54

67

Cash and cash equivalents

5

7,666

6,231

7,275

31,694

29,197

29,511

Current liabilities

Trade and other payables

(13,893)

(16,027)

(14,228)

Current tax liabilities

(1,196)

(865)

(875)

Bank overdraft and loans

(988)

(933)

(1,000)

Derivative financial instruments

(268)

(134)

(99)

(16,345)

(17,959)

(16,202)

Net current assets

15,349

11,238

13,309

Non-current liabilities

Bank loans

(9,708)

(11,056)

(10,145)

Retirement benefit obligations

(8,425)

(7,025)

(8,494)

Provisions for other liabilities and charges

(122)

(112)

(116)

(18,255)

(18,193)

(18,755)

Net assets

47,650

43,864

45,174

Capital and reserves

Share capital

6

867

852

852

Share premium account

6

34,732

34,511

34,511

Cumulative translation reserve

7

935

1,029

612

Retained earnings

7

11,116

7,472

9,199

Total equity

47,650

43,864

45,174

 

The interim financial information on pages 6 to 16 were approved by the Board of Directors on 21 June 2013 and were signed on its behalf by:

 

Ben Stocks Chris Tyler

Group Chief Executive Group Finance Director

 

The accompanying notes are an integral part of this interim financial information.

Consolidated cash flow statement

For the six months ended 31 May

Six months ended 31 May

Note

2013 Unaudited

2012 Unaudited

£'000

£'000

Cash flows from operating activities

Cash generated from operations

8

1,966

3,924

Interest paid

(185)

(269)

Tax paid

(838)

(345)

Net cash generated from operating activities

943

3,310

Cash flows from investing activities

Acquisition of subsidiaries (net of cash acquired)

(63)

(3,076)

Purchase of property, plant and equipment

4

(374)

(860)

Purchase of intangible assets

4

(153)

(11)

Proceeds from sale of property, plant and equipment

478

101

Net cash used in investing activities

(112)

(3,846)

Cash flows from financing activities

Net proceeds from the issue of ordinary shares

6

236

41

(Repayment of)/increase in borrowings

9

(886)

1,621

Capital element of finance leases

9

-

(6)

Net cash generated from/(used in) financing activities

(650)

1,656

Net increase in cash and cash equivalents

9

181

1,120

Effects of exchange rate changes

210

-

391

1,120

Cash and cash equivalents at the beginning of the period

7,275

5,111

Cash and cash equivalents at the end of the period

5

7,666

6,231

 

 

The accompanying notes are an integral part of this interim financial information.

Consolidated statement of changes in equity

For the six months ended 31 May (Unaudited)

 

 

 

Share capital

£'000

Share premium account

£'000

Cumulative translation

reserve

£'000

 

Retained earnings

£'000

 

 

Total

£'000

Balance at 1 December 2011

851

34,471

883

5,886

42,091

Profit for the period

-

-

-

1,689

1,689

Other comprehensive income for the period:

Exchange differences on translation of foreign subsidiaries

 

-

 

-

 

146

 

-

 

146

Changes in fair value of interest rate swaps held as a cash flow hedge

 

-

 

-

 

-

 

46

 

46

Total comprehensive income for the period

 

-

 

-

 

146

 

1,735

 

1,881

Transactions with owners:

Proceeds from shares issued, net of costs

 

1

 

40

 

-

 

-

 

41

Employee share option schemes:

Value of employee services net of tax

-

-

-

448

448

Dividends approved as final or paid

-

-

-

(597)

(597)

Balance at 31 May 2012

852

34,511

1,029

7,472

43,864

Balance at 1 December 2012

852

34,511

612

9,199

45,174

Profit for the period

-

-

-

2,099

2,099

Other comprehensive income for the period:

Exchange differences on translation of foreign subsidiaries

-

-

323

-

323

Changes in fair value of interest rate swaps held as a cash flow hedge

 

-

 

-

 

-

 

34

 

34

Total comprehensive income for the period

-

-

323

2,133

2,456

Transactions with owners:

Proceeds from shares issued, net of costs

 

15

 

221

 

-

 

-

 

236

Employee share option schemes:

Value of employee services net of tax

-

-

-

478

478

Dividends approved as final or paid

-

-

-

(694)

(694)

Balance at 31 May 2013

867

34,732

935

11,116

47,650

 

The accompanying notes are an integral part of this interim financial information.

 

Notes to the financial information

 

1. Segmental analyses

 

The chief operating decision maker has been identified as the Board of Directors. The Board of Directors review the Group's internal reporting in order to assess performance and allocate resources. Management have determined the operating segments based on this reporting.

 

As at 31 May 2013, the Group is organised on a worldwide basis into two operating segments:

1) Metals Filtration

2) Microfiltration

 

The segment results for the period ended 31 May 2013 are as follows:

 

Six months ended 31 May 2013 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Revenue

14,081

24,523

-

38,604

Operating profit/(loss)

1,075

3,461

(1,076)

3,460

Interest payable and similar charges

-

-

(410)

(410)

Profit/(loss) before income tax

1,075

3,461

(1,486)

3,050

Income tax expense

-

-

(951)

(951)

Profit/(loss) for the period

1,075

3,461

(2,437)

2,099

 

The segment results for the period ended 31 May 2012 are as follows:

 

Six months ended 31 May 2012 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Revenue

14,596

21,270

-

35,866

Operating profit/(loss)

1,213

2,422

(818)

2,817

Interest payable and similar charges

-

-

(410)

(410)

Profit/(loss) before income tax

1,213

2,422

(1,228)

2,407

Income tax expense

-

-

(718)

(718)

Profit/(loss) for the period

1,213

2,422

(1,946)

1,689

 

Other Group operations are included in "Other unallocated". These mainly comprises Group corporate costs and include new business development costs, some research and development costs and general financial costs.

Segment assets and liabilities

 

At 31 May 2013 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

24,896

45,914

3,774

74,584

Cash and cash equivalents

-

-

7,666

7,666

Total assets

24,896

45,914

11,440

82,250

Segmental liabilities

(2,794)

(9,784)

(2,901)

(15,479)

Retirement benefit obligations

-

-

(8,425)

(8,425)

Borrowings

-

-

(10,696)

(10,696)

Total liabilities

(2,794)

(9,784)

(22,022)

(34,600)

 

At 31 May 2012 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

26,149

44,891

2,745

73,785

Cash and cash equivalents

-

-

6,231

6,231

Total assets

26,149

44,891

8,976

80,016

Segmental liabilities

(3,600)

(11,292)

(2,246)

(17,138)

Retirement benefit obligations

-

-

(7,025)

(7,025)

Borrowings

-

-

(11,989)

(11,989)

Total liabilities

(3,600)

(11,292)

(21,260)

(36,152)

 

At 30 November 2012 - Audited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

24,362

45,285

3,209

72,856

Cash and cash equivalents

-

-

7,275

7,275

Total assets

24,362

45,285

10,484

80,131

Segmental liabilities

(3,102)

(10,059)

(2,157)

(15,318)

Retirement benefit obligations

-

-

(8,494)

(8,494)

Borrowings

-

-

(11,145)

(11,145)

Total liabilities

(3,102)

(10,059)

(21,796)

(34,957)

 

 

Geographical analysis

Revenue

Six months ended 31 May

2013

Unaudited

2012

Unaudited

By destination

£'000

By origin

£'000

By destination

£'000

By origin

£'000

United Kingdom

7,901

15,759

7,099

15,011

Continental Europe

5,838

3,035

5,578

2,809

United States of America

16,467

18,962

14,576

17,295

Other NAFTA

1,626

-

2,149

-

South America

697

-

1,011

-

Asia

4,733

848

4,201

751

Australasia

622

-

606

-

Africa

720

-

646

-

38,604

38,604

35,866

35,866

 

 

2. Earnings per share

Six months ended 31 May

2013

Unaudited

2012

Unaudited

Earnings

 

 

 

£'000

Weighted average number of shares

Per share amount

 

 

Pence

Earnings

 

 

 

£'000

Weighted average number of shares

Per share amount

 

 

Pence

Basic EPS - Earnings attributable to ordinary shareholders

 

 

2,099

 

 

42,813,469

 

 

4.9

 

 

1,689

 

 

42,575,320

 

 

4.0

Effect of dilutive securities - share options

 

-

 

363,563

 

-

 

-

 

137,655

 

-

Diluted EPS

2,099

43,177,032

4.9

1,689

42,712,975

4.0

 

 

3. Dividends per share

Six months ended 31 May

2013

2012

Unaudited

Unaudited

Per share

£'000

Per share

£'000

Final dividend approved

1.60p

694

1.40p

597

 

The final dividend approved was paid to shareholders on 7 June 2013.

 

The Directors have declared an interim dividend of 1.1 pence (2012: 1.0 pence) per share to be paid on 6 September 2013 to shareholders on the register at the close of business on 2 August 2013. The ex-dividend date for the shares is 31 July 2013.

 

4. Property, plant and equipment and goodwill and other intangible assets

 

Six months ended 31 May 2013 - Unaudited

Property, plant and equipment

Goodwill and other intangible assets

Total

£'000

£'000

£'000

Opening net book amount at 1 December 2012

8,641

39,983

48,624

Additions

374

153

527

Disposals

(360)

-

(360)

Depreciation and amortisation

(735)

(181)

(916)

Exchange movements

265

31

296

Closing net book amount at 31 May 2013

8,185

39,986

48,171

 

 

Six months ended 31 May 2012 - Unaudited

Property, plant and equipment

Goodwill and other intangible assets

Total

£'000

£'000

£'000

Opening net book amount at 1 December 2011

8,213

37,070

45,283

Additions

860

11

871

Acquisitions

91

3,188

3,279

Disposals

(13)

-

(13)

Depreciation and amortisation

(595)

(154)

(749)

Exchange movements

89

257

346

Closing net book amount at 31 May 2012

8,645

40,372

49,017

 

5. Cash and cash equivalents

 

As at 31 May

As at 30 November

2013

Unaudited

£'000

2012

Unaudited

£'000

2012

Audited

£'000

Cash at bank and in hand

7,666

4,510

5,863

Restricted cash

-

1,721

1,412

Cash and cash equivalents

7,666

6,231

7,275

 

Cash and cash equivalents include restricted balances of £nil (2012: £1.7m). At 31 May and 30 November 2012 $2,263,000 was held as a guarantee by a UK bank against the advance payment bond in relation to the POSCO contract. At 31 May 2012 Can$400,000 was held in escrow as contingent consideration relating to the acquisition of Pulse Instrumentation.

 

6. Share capital and premium

Number of shares (thousands)

Ordinary shares

Unaudited

Share premium account

Unaudited

 

Total

Unaudited

£'000

£'000

£'000

At 1 December 2011

42,561

851

34,471

35,322

Employee share options schemes:

Exercise of options under share option schemes

 

52

 

1

 

40

 

41

At 31 May 2012

42,613

852

34,511

35,363

At 1 December 2012

42,613

852

34,511

35,363

Employee share options schemes:

Exercise of options under share option schemes

 

748

 

15

 

221

 

236

At 31 May 2013

43,361

867

34,732

35,599

 

The authorised number of ordinary shares is 75 million (2012: 75 million) shares with a par value of 2.0 pence (2012: 2.0 pence) per share. All issued shares are fully paid. 748,500 ordinary shares of 2p each were issued in the period on the exercise of employee share options for a cash consideration of £236,000.

 

7. Other reserves

Cumulative translation reserve

Unaudited

 

Retained earnings

Unaudited

£'000

£'000

At 1 December 2011

883

5,886

Profit for the period attributable to shareholders

-

1,689

Direct to equity:

Final dividends approved

-

(597)

Share based payments

-

146

Tax on share based payments

-

302

Interest rate swap cash flow hedge

-

46

Exchange differences

146

-

At 31 May 2012

1,029

7,472

At 1 December 2012

612

9,199

Profit for the period attributable to shareholders

-

2,099

Direct to equity:

-

Final dividends approved

-

(694)

Share based payments

-

208

Tax on share based payments

-

270

Interest rate swap cash flow hedge

-

34

Exchange differences

323

-

At 31 May 2013

935

11,116

 

8. Cash generated from operations

Six months ended 31 May

2013

Unaudited

£'000

2012

Unaudited

£'000

Operating profit

3,460

2,817

Non-cash pension charge

150

100

Share based payments

208

146

Depreciation and amortisation

916

749

Profit on disposal of property, plant and equipment

(118)

(88)

Operating cash flows before movement in working capital

4,616

3,724

Increase in inventories

(673)

(1,369)

Increase in trade and other receivables

(494)

(604)

(Decrease)/ increase in payables

(1,483)

2,173

(Increase)/decrease in working capital

(2,650)

200

Cash generated from operations

1,966

3,924

 

9. Reconciliation of net cash flow to movement in net debt

Six months ended 31 May

2013

Unaudited

£'000

2012

Unaudited

£'000

Net increase in cash and cash equivalents

181

1,120

Effects of exchange rate changes

(227)

(172)

Repayment of/(increase in) borrowings

886

(1,621)

Repayment of finance leases

-

6

Net debt at the beginning of the period

(3,870)

(5,091)

Net debt at the end of the period

(3,030)

(5,758)

 

10. Post balance sheet event - Acquisition

The goodwill, business and trading assets of Eisenmann Metallurgical LLC, trading as Chand Eisenmann Metallurgical ("CEM"), were acquired on 4 June 2013 for a total consideration of $5.5 million in cash and deferred consideration. CEM designs and manufactures sintered metal filters from a facility in Caribou, Maine.

 

11. Exchange rates

Exchange rates for the US dollar during the period were:

Average rate to 31 May 13

Average rate to 31 May 12

Closing rate at 31 May 13

Closing rate at 30 Nov 12

Unaudited

Unaudited

Unaudited

Unaudited

US dollar

1.55

1.58

1.52

1.60

 

12. Seasonality

The results for the six months ended 31 May 2013 are impacted by a lower number of working days in the first six months of the year than in the second half of the year.

 

13. Basis of preparation

Porvair plc is a public limited company registered in the UK and listed on the London Stock Exchange.

 

This unaudited condensed half-yearly consolidated financial information for the six months ended 31 May 2013 has been prepared in accordance with the Disclosure and Transparency Rules ('DTR') of the Financial Conduct Authority and with IAS 34, 'Interim financial reporting' as adopted by the European Union. The condensed half-yearly consolidated financial information should be read in conjunction with the annual financial statements for the year ended 30 November 2012, which have been prepared in accordance with IFRSs as adopted by the European Union.

 

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 November 2012, as described in those financial statements. As at the date of signing the interim financial statements, there are no new standards likely to affect the financial statements for the year ending 30 November 2013.

 

Taxes on income in the interim period are accrued using the tax rate that would be applicable to expected total annual earnings.

 

This condensed half-yearly consolidated financial information has been prepared on a going concern basis under the historical cost convention, as modified by the revaluation of certain current assets, financial assets and financial liabilities held for trading and derivative contracts, which are held at fair value.

 

The preparation of condensed half-yearly consolidated financial information in conformity with generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed half-yearly consolidated financial information and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results may ultimately differ from those estimates.

 

After having made appropriate enquiries, including a review of progress against the Group's budget for 2013, its medium term plans and taking into account the banking facilities available until January 2018, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing this condensed half-yearly consolidated financial information.

 

This condensed half-yearly consolidated financial information and the comparative figures does not constitute full accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 November 2012, which include an unqualified audit report, no emphasis of matter paragraph and no statements under sections 498(2) or (3) of the Companies Act 2006, have been delivered to the Registrar of Companies.

 

This report will be available at Porvair plc's registered office at 7 Regis Place, Bergen Way, King's Lynn, PE30 2JN and on the Company's website www.porvair.com.

 

 

Statement of directors' responsibilities

 

The Directors confirm that this condensed half-yearly consolidated financial information has been prepared in accordance with IAS 34 as adopted by the European Union and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:

§ an indication of important events that have occurred during the first six months of the year, their impact on the condensed half-yearly consolidated financial information and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

§ material related party transactions in the first six months of the year and any material changes in the related party transactions described in the last annual report.

 

The directors of Porvair plc are listed in the Porvair plc Annual Report for the year ended 30 November 2012. Michael Gatenby resigned from the Board at the Annual General Meeting on 16 April 2013. A list of current directors is maintained on the Porvair plc website www.porvair.com.

 

By order of the board

 

 

 

 

Ben Stocks

Group Chief Executive

 

 

 

 

Chris Tyler

Group Finance Director

 

21 June 2013

 

 

Independent review report to Porvair plc

 

Introduction

We have been engaged by the company to review the condensed half-yearly consolidated financial information in the half-yearly financial report for the six months ended 31 May 2013, which comprises the consolidated income statement, the consolidated statement of comprehensive income, the consolidated balance sheet, the consolidated cash flow statement, the consolidated statement of changes in equity and the related notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed half-yearly consolidated financial information.

 

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

As disclosed in note 13, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The condensed half-yearly consolidated financial information included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union.

 

Our responsibility

Our responsibility is to express to the company a conclusion on the condensed half-yearly consolidated financial information in the half-yearly financial report based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of the Disclosure and Transparency Rules of the Financial Conduct Authority and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

 

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed half-yearly consolidated financial information in the half-yearly financial report for the six months ended 31 May 2013 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

 

 

PricewaterhouseCoopers LLPChartered Accountants21 June 2013Cambridge

 

Notes:

 

(a) The maintenance and integrity of the Porvair plc website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the condensed half-yearly consolidated financial information since it was initially presented on the website.

 

(b) Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BUGDLBDDBGXB
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.